Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 In vivo response of P. falciparum to SP during the extended period of follow up after cessation of sIPT implementation per age categories and treatment group

From: Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali

  1–4 years 5–11 years All
Outcome sIPT-
(n = 102)
sIPT +
(n = 104)
sIPT-
(n = 130)
sIPT +
(n = 136)
sIPT-
(n = 232)
sIPT +
(n = 240)
ACPR 87.3 84.6 88.5 93.4 87.9 89.6
ETF 0.0 1.0 1.5 0.7 0.9 0.8
LCF 1.0 0.0 0.0 0.0 0.4 0.0
LPF 11.8 14.4 10.0 5.9 10.8 9.6
  1. sIPT - = control group
  2. sIPT + = treatment group
  3. ACPR = adequate clinical and parasitological response
  4. ETF = early treatment failure
  5. LPF = late parasitological failure